Trial intelligence / Profile preview

Eribulin plus capecitabine versus capecitabine in previously treated HER2-negative advanced or metastatic breast cancer

ChiCTR2100052828Phase 4Recruiting

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Start

Sep 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1